87 related articles for article (PubMed ID: 947956)
21. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin.
Ratnoff OD
J Lab Clin Med; 1980 Aug; 96(2):267-77. PubMed ID: 7400662
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
Schreiber AD; Kaplan AP; Austen KF
J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
[TBL] [Abstract][Full Text] [Related]
23. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
[TBL] [Abstract][Full Text] [Related]
24. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
[TBL] [Abstract][Full Text] [Related]
25. Production and characterization of a murine monoclonal antibody against a heavy chain of Hageman factor (factor XII).
Saito H; Ishihara T; Suzuki H; Watanabe T
Blood; 1985 May; 65(5):1263-8. PubMed ID: 3922451
[TBL] [Abstract][Full Text] [Related]
26. [Isolation and some properties of Hageman factor and its active fragment from human blood].
Krizhevskaia IuV; Iarovaia GA; Dotsenko VL; Khvatov VB
Biokhimiia; 1981 Aug; 46(8):1510-8. PubMed ID: 7272366
[TBL] [Abstract][Full Text] [Related]
27. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
Derkx FH; Bouma BN; Schalekamp MA
J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
[TBL] [Abstract][Full Text] [Related]
28. Hageman factor: its structure and modes of activation.
Revak SD; Cochrane CG
Thromb Haemost; 1976 Jun; 35(3):570-5. PubMed ID: 989964
[No Abstract] [Full Text] [Related]
29. Studies on contact activation: effects of surface and inhibitors.
Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
[TBL] [Abstract][Full Text] [Related]
30. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
Schousboe I
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
[TBL] [Abstract][Full Text] [Related]
31. Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome.
Hruby MA; Honig GR; Shapira E
J Lab Clin Med; 1980 Sep; 96(3):501-10. PubMed ID: 6772722
[TBL] [Abstract][Full Text] [Related]
32. Immunochemical studies of plasma kallikrein.
Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
[TBL] [Abstract][Full Text] [Related]
33. Amidolytic properties of single-chain activated Hageman factor.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1461-3. PubMed ID: 286331
[TBL] [Abstract][Full Text] [Related]
34. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
Gordon EM; Ratnoff OD; Goldsmith GH
J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
[TBL] [Abstract][Full Text] [Related]
35. Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.
Saito H; Scialla SJ
J Clin Invest; 1981 Oct; 68(4):1028-35. PubMed ID: 6793628
[TBL] [Abstract][Full Text] [Related]
36. Formation and structure of human Hageman factor fragments.
Dunn JT; Kaplan AP
J Clin Invest; 1982 Sep; 70(3):627-31. PubMed ID: 6921203
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).
Griffin JH; Beretta G
Adv Exp Med Biol; 1979; 120B():39-51. PubMed ID: 517240
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody that inhibits activation of human Hageman factor (factor XII).
Small EJ; Katzmann JA; Tracy RP; Ratnoff OD; Goldsmith GH; Everson B
Blood; 1985 Jan; 65(1):202-10. PubMed ID: 3965048
[TBL] [Abstract][Full Text] [Related]
39. Activation of factor XII (Hageman factor): enhancing effect of a potentiator.
Chan JY; Burrowes CE; Movat HZ
Thromb Res; 1977 Feb; 10(2):309-13. PubMed ID: 850912
[No Abstract] [Full Text] [Related]
40. The binding of bovine factor XII to kaolin.
Kirby EP; McDevitt PJ
Blood; 1983 Apr; 61(4):652-9. PubMed ID: 6187393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
